Semnur Pharmaceuticals, Inc.
SMNRW- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001913577
No open-market purchases or sales by Semnur Pharmaceuticals, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesSMNR
13F holders, Q2 2023
Institutional positions in Semnur Pharmaceuticals, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- −1 vs. Q1 2023
- Shares held
- 7.59M
- −134.4K (−1.7%) vs. Q1 2023
- Total value
- $381.8K
- −$39.4K (−9.3%) vs. Q1 2023
- New holders
- 0
- 1 more added
- Sold out
- 1
- 2 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SMNRW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 3 | $59.8K |
| Q1 2025 | 19 | $319.8K |
| Q4 2024 | 19 | $213.6K |
| Q3 2024 | 22 | $343.3K |
| Q2 2024 | 20 | $107.8K |
| Q1 2024 | 25 | $279.6K |
| Q4 2023 | 28 | $321.3K |
| Q3 2023 | 29 | $435.8K |
| Q2 2023 | 27 | $381.8K |
| Q1 2023 | 28 | $421.2K |
| Q4 2022 | 25 | $244.2K |
| Q3 2022 | 25 | $486.1K |
| Q2 2022 | 13 | $440.0K |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Semnur Pharmaceuticals, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Polar Asset Management Partners Inc. | 1,400,000 | $87.1K | 0.00% | 00.0% | Unchanged |
| Context Capital Management, LLC | 605,000 | $38.0K | 0.00% | 00.0% | Unchanged |
| Shaolin Capital Management LLC | 573,900 | $29.0K | 0.00% | 00.0% | Unchanged |
| Atw Spac Management LLC | 470,000 | $23.5K | 0.02% | 00.0% | Unchanged |
| Hudson Bay Capital Management LP | 465,000 | $23.3K | 0.00% | 00.0% | Unchanged |
| Calamos Advisors LLC | 350,000 | $21.8K | 0.00% | 00.0% | Unchanged |
| Saba Capital Management, L.P. | 410,000 | $20.5K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 393,423 | $19.7K | 0.00% | 00.0% | Unchanged |
| Arena Investors LP | 225,000 | $14.0K | 0.01% | 00.0% | Unchanged |
| Taconic Capital Advisors LP | 257,500 | $12.9K | 0.00% | 00.0% | Unchanged |
| Periscope Capital Inc. | 199,500 | $12.4K | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 225,000 | $11.3K | 0.00% | 00.0% | Unchanged |
| Whitebox Advisors LLC | 200,000 | $10.0K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 162,419 | $8.12K | 0.00% | 00.0% | Unchanged |
| CNH Partners LLC | 162,244 | $8.11K | 0.00% | −936−0.6% | Reduced |
| Rivernorth Capital Management, LLC | 154,800 | $7.74K | 0.00% | 00.0% | Unchanged |
| Spartan Fund Management Inc. | 116,512 | $7.25K | 0.00% | 00.0% | Unchanged |
| Clear Street LLC | 130,409 | $6.52K | 0.00% | +16,650+14.6% | Added |
| Lynwood Capital Management Inc. | 104,500 | $5.22K | 0.01% | 00.0% | Unchanged |
| Fifth Lane Capital, LP | 72,500 | $4.51K | 0.00% | 00.0% | Unchanged |
| Meteora Capital, LLC | 68,878 | $4.28K | 0.00% | 00.0% | Unchanged |
| III Capital Management | 41,184 | $2.56K | 0.00% | 00.0% | Unchanged |
| CVI Holdings, LLC | 40,945 | $2.05K | 0.00% | −100−0.2% | Reduced |
| Schonfeld Strategic Advisors LLC | 20,000 | $1.24K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 18,560 | $928 | 0.00% | 00.0% | Unchanged |
| Mangrove Partners | 255,181 | – | – | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 470,000 | – | – | 00.0% | Unchanged |
| Ionic Capital Management LLC | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |